期刊文献+

基于巨噬细胞极化调控心肌细胞代谢重塑探讨暖心康改善心肌梗死小鼠心肌纤维化的机制

To Explore the Mechanism of Nuanxinkang on Alleviating Myocardial Fibrosis in Mice with Myocardial Infarction Through Regulation of Myocardial Cell Metabolic Remodeling Based on Macrophage Polarization
下载PDF
导出
摘要 目的基于巨噬细胞极化调控心肌细胞代谢重塑探讨暖心康(红参、毛冬青)改善心肌梗死小鼠心肌纤维化的机制。方法(1)将C57BL/6J雄性小鼠随机分为3组:假手术组、模型组、暖心康组(1.65 g·kg^(-1)),每组10只。采用结扎冠状动脉术复制心肌梗死小鼠模型。灌胃给药,每日1次,连续4周。采用Masson染色法检测心肌组织纤维化;qPCR法检测心脏组织中LDHA、HK2、CD36、CPT-1A、PPAR-γ、PGC-1α、Ndufa8、SDHd、Cyc1、Cox4i2、CD86、iNOS、TNF-αmRNA表达水平;ELISA法检测血清炎症因子IL-1β的水平。(2)采用脂多糖诱导RAW264.7巨噬细胞向促炎型巨噬细胞极化,制备促炎型巨噬细胞上清液,将其作用于HL-1心肌细胞模型。HL-1心肌细胞分组与RAW264.7巨噬细胞分组相同:空白血清对照组(含5%空白血清+5%胎牛血清的培养基)、暖心康含药血清组(含5%暖心康含药血清+5%胎牛血清的培养基)、脂多糖组(含5%空白血清+5%胎牛血清的培养基+200μg·mL^(-1)脂多糖)和暖心康含药血清+脂多糖组(含5%暖心康含药血清+5%胎牛血清的培养基+200μg·mL^(-1)脂多糖),均干预24 h。采用油红O染色检测心肌细胞中脂质分布情况;DCFH-DA荧光探针检测细胞ROS水平。结果(1)与模型组比较,暖心康组小鼠心脏组织胶原沉积面积显著减少(P<0.01),且梗死区域局部室壁损伤程度减轻;心脏组织中LDHA、HK2、CD36、CPT-1A、PPAR-γ、Ndufa8、SDHd、Cyc1、Cox4i2、CD86、iNOS、TNF-αmRNA表达水平显著降低(P<0.05,P<0.01,P<0.001),PGC-1αmRNA表达水平明显升高(P<0.05);血清IL-1β水平显著降低(P<0.001)。(2)与脂多糖组比较,暖心康含药血清+脂多糖组HL-1心肌细胞胞浆内的脂滴沉积明显减少(P<0.05),ROS水平显著降低(P<0.001)。结论暖心康能够减轻心肌梗死小鼠的心肌纤维化及心室重构,其作用机制可能与抑制促炎型巨噬细胞极化,降低炎症水平,减少ROS生成,降低心脏组织糖酵解水平,改善氧化磷酸化和脂肪酸代谢有关。 Objective To explore the mechanism of Nuanxinkang(NXK,composed of Ginseng Radix et Rhizoma Rubra and Ilex Pubescen)on alleviating myocardial fibrosis in mice with myocardial infarction by orchestrating myocardial cell metabolic remodeling based on macrophage polarization.Methods(1)C57BL/6J male mice were randomly divided into three groups:sham operation group,model group and NXK administration group(1.65 g·kg^(-1)),with 10 rats in each group.The myocardial infarction model of mice was induced by ligating coronary artery.The drug administration group was given NXK once a day for four weeks.Masson staining was used to detect myocardial fibrosis,and quantitative PCR was used to detect the mRNA expression levels of LDHA,HK2,CD36,CPT-1A,PPAR-γ,PGC-1α,Ndufa8,SDHd,Cyc1,Cox4i2,CD86,iNOS and TNF-αin cardiac tissues.The content of inflammatory factor IL-1βin serum was detected by ELISA.(2)Lipopolysaccharide(LPS)was used to induce the polarization of RAW264.7 macrophages into pro-inflammatory subtype.The supernatant fluid of pro-inflammatory macrophages was prepared and subsequently acted on HL-1 cardiomyocytes.RAW264.7 macrophages and HL-1 cardiomyocytes were divided into control serum group(culture medium with 5%blank serum and 5%fetal bovine serum),NXK-contained serum group(culture medium with 5%NXK-contained serum and 5%fetal bovine serum),LPS treatment group(culture medium with 5%blank serum,5%fetal bovine serum and 200μg·mL^(-1)LPS)and NXK-contained serum+LPS treatment group(culture medium with 5%NXK-contained serum,5%fetal bovine serum and 200μg·mL^(-1)LPS).After 24-h intervention in each group,the lipid in the cells was labeled by Oil Red O staining,and the reactive oxygen species(ROS)level of the cells was detected by DCFH-DA fluorescent probe.Results(1)Compared with the model group,collagen deposition area in cardiac tissue of mice was remarkably reduced(P<0.01)and local ventricular wall damage in the infarcted area was alleviated in NXK group.Also,the mRNA expressions of LDHA,HK2,CD36,CPT-1A,PPAR-γ,Ndufa8,SDHd,Cyc1,Cox4i2,CD86,iNOS and TNF-αwere significantly decreased(P<0.05,P<0.01,P<0.001).The mRNA expression of PGC-1αwas significantly increased(P<0.05).Serum IL-1βlevel was obviously decreased(P<0.001).(2)Compared with the LPS group,the deposition of lipid droplets in cytoplasm of HL-1 cardiomyocytes in NXK-contained serum+LPS treatment group was remarkably reduced(P<0.05)and ROS level decreased significantly(P<0.001).Conclusion NXK can alleviate myocardial fibrosis and ventricular remodeling after myocardial infarction in mice,and its mechanism may be related to inhibiting the polarization of pro-inflammatory macrophages,alleviating inflammation level,reducing the production of ROS,reducing the level of glycolysis in cardiac tissue,and improving oxidative phosphorylation and fatty acid metabolism.
作者 林祉均 何欢 陈梓欣 陈洁 方红城 王陵军 LIN Zhijun;HE Huan;CHEN Zixin;CHEN Jie;FANG Hongcheng;WANG Lingjun(State Key Laboratory of Traditional Chinese Medicine Syndrome,the First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510405 Guangdong,China;Shenzhen Integrated Traditional Chinese and Western Medicine Hospital,Shenzhen 518104 Guangdong,China)
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2024年第11期1637-1644,共8页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 国家自然科学基金青年项目(82004293)。
关键词 暖心康 心肌梗死 心肌纤维化 巨噬细胞极化 炎症反应 氧化应激 能量代谢重塑 小鼠 RAW264.7巨噬细胞 HL-1心肌细胞 Nuanxinkang myocardial infarction myocardial fibrosis macrophage polarization inflammatory response oxidative stress energy metabolism remodeling mice RAW264.7 macrophages HL-1 cardiomyocytes
  • 相关文献

参考文献7

二级参考文献66

  • 1中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:845
  • 2范谦,王跃民,马新亮,高峰.小鼠心肌缺血/再灌注模型制备方法的改良[J].心脏杂志,2004,16(6):584-584. 被引量:10
  • 3文重远,吴勇,李燕,陈小琳,王腾,欧阳静萍,李庚山.2型糖尿病大鼠心肌葡萄糖转运体4的变化及其对葡萄糖和脂肪酸代谢的影响[J].中华医学杂志,2005,85(21):1460-1463. 被引量:12
  • 4殷然,董吁钢,李红良,刘丹.AMPK通过增强心肌脂肪酸氧化抑制大鼠心肌肥厚[J].中国病理生理杂志,2007,23(7):1258-1262. 被引量:8
  • 5中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(1):98-122.
  • 6Fu SF, Zhang JH, Gao XM, et al. Clinical practice of tra- ditional Chinese medicines for chronic heart failure [ J ]. Heart Asia, 2010,2:24 - 27. doi. 10.1136/ha. 2009. 001123.
  • 7Mao J, Hou Y, Shang H, et al. Study on the evaluation of the clinical effects of traditional chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF [J] . Trials,2009, 24; 10: 122. doi: 10. 1186/1745 - 6215 - 10 - 122.
  • 8毛静远,李国政,崔小磊,等.中医药治疗心力衰竭用药规律的文献研究[C]//中华中医药学会心病分会,中华中医药学会心病分会第十次全国中医心病学术年会暨吉林省中医药学会心病第二次学术会议论文精选,2008:269-276.
  • 9Li X, Zhang J, Huang J, et al. A Multicenter Randomized Double-Blind Parallel-Group Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients with Chronic Heart Failure[J]. J Am Coll Cardiol,2013, 62 (12) : 1065 - 1072.
  • 10吴喜庆,宋俊生,陆小左.真武汤及其加减方治疗心力衰竭临床对照试验的系统评价[J].天津中医药,2008,25(6):477-479. 被引量:14

共引文献787

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部